HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nancy Alvandi Selected Research

Oxymetazoline

1/2021Oxymetazoline and Energy-Based Therapy in Patients with Rosacea: Evaluation of the Safety and Tolerability in an Open-Label, Interventional Study.
11/2018Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials
6/2018Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0.
6/2018Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
1/2018WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
1/2018Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nancy Alvandi Research Topics

Disease

7Acne Vulgaris
01/2019 - 02/2018
6Erythema
01/2021 - 01/2018
6Rosacea (Acne Rosacea)
01/2021 - 01/2018
1Body Weight (Weight, Body)
01/2019
1Inflammation (Inflammations)
01/2019
1Sepsis (Septicemia)
01/2019
1Overactive Urinary Bladder (Overactive Bladder)
10/2018
1Disease Progression
06/2018

Drug/Important Bio-Agent (IBA)

6OxymetazolineFDA Link
01/2021 - 01/2018
6DapsoneFDA Link
01/2019 - 02/2018
2gallium arsenide (GaAs)IBA
06/2018 - 02/2018
1sarecyclineIBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
01/2019
1Doxycycline (Periostat)FDA LinkGeneric
01/2019
1Tetracycline (Achromycin)FDA LinkGeneric
01/2019
1Cholinergic Antagonists (Anticholinergics)IBA
10/2018
1Type A Botulinum Toxins (Botox)FDA Link
10/2018

Therapy/Procedure

2Therapeutics
01/2021 - 06/2018